These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


426 related items for PubMed ID: 6205848

  • 1. [NK cells--their role and importance in antitumor resistance].
    Mircheva Zh.
    Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
    [No Abstract] [Full Text] [Related]

  • 2. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM, Adamczyk MB.
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens.
    Hokland ME.
    Acta Pathol Microbiol Immunol Scand Suppl; 1985; 286():1-35. PubMed ID: 2408439
    [No Abstract] [Full Text] [Related]

  • 5. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C, Fleckenstein K, Lohr J, Li CY, Wenz F, Lohr F.
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [Abstract] [Full Text] [Related]

  • 6. Natural cytotoxic activity in murine and human systems. A review.
    Lattime EC.
    Year Immunol; 1986 Apr; 2():261-6. PubMed ID: 3554823
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Natural killer (NK) cells.
    Herberman RB.
    Prog Clin Biol Res; 1981 Apr; 58():33-43. PubMed ID: 6167995
    [No Abstract] [Full Text] [Related]

  • 9. Natural killer (NK) cells and their possible roles in resistance against disease.
    Herberman RB.
    Clin Immunol Rev; 1981 Apr; 1(1):1-65. PubMed ID: 6219848
    [No Abstract] [Full Text] [Related]

  • 10. [Characteristics of the NK cells in Syrian hamsters carrying tumors with varying metastatic and resistance-suppressing activity].
    Kliuchareva TE, Matveeva VA.
    Biull Eksp Biol Med; 1985 Jun; 99(6):732-4. PubMed ID: 4016267
    [Abstract] [Full Text] [Related]

  • 11. An introduction to tumour immunology.
    James K.
    Arch Immunol Ther Exp (Warsz); 1983 Jun; 31(6):795-808. PubMed ID: 6611141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Types of cellular antitumor cytotoxicity].
    Lomakin MS, Maĭskiĭ IN.
    Vopr Onkol; 1988 Jun; 34(12):1422-32. PubMed ID: 2975420
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Experimental studies and clinical investigations on natural killer (NK) activity--NK activity in tumor bearing nude mice and in patients with cancer of digestive organs].
    Maenohara S.
    Igaku Kenkyu; 1984 Apr; 54(3):301-16. PubMed ID: 6532057
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An introduction to tumour immunology.
    Keith J.
    Mater Med Pol; 1984 Apr; 16(1):54-64. PubMed ID: 6394909
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.